Senate Bill 1626, also known as House Bill 1775, amends Tennessee law to enhance coverage for cancer testing under health plans. The bill introduces a new section to Tennessee Code Annotated, Title 56, Chapter 7, Part 10, which mandates that health plans must provide coverage for clinical genetic testing for inherited gene mutations and evidence-based cancer imaging for individuals at increased risk of cancer, as recommended by healthcare professionals and aligned with the National Comprehensive Cancer Network (NCCN) clinical practice guidelines.

Importantly, the coverage required by the bill is exempt from any cost-sharing requirements, meaning that individuals will not incur out-of-pocket expenses such as deductibles or copayments for these services. Additionally, the bill addresses the implications for health savings accounts, ensuring that the coverage requirements apply even for high deductible health plans after the minimum deductible has been met, except for preventive care services. The act is set to take effect on July 1, 2026, and will apply to plans issued, amended, or renewed on or after that date.